P436 Evaluation of targeted vitamin D supplementation regimen in postoperative patients with Crohn’s disease

Y LI,L Zheng,D Yao,Z Zhou,B Liu,Y Huang,Y Duan
DOI: https://doi.org/10.1093/ecco-jcc/jjz203.565
2020-01-01
Journal of Crohn's and Colitis
Abstract:Abstract Background Vitamin D with a serum 25(OH)D concentration above 100 nmol/l was associated with disease remission in patients with IBD and suggested that targeted administration may be an anti-inflammatory drug. This study was designed to assess the effectiveness, safety, and predictive measures of a vitamin D regimen in postoperative patients with Crohn’s disease to achieve the above goals. Methods In a prospective study, patients with Crohn’s disease and serum 25(OH)D concentrations <75 nmol / L were prescribed an oral vitamin D supplement at a dose of one year, and adjusted 4-weekly to aim for a serum 25(OH)D level of 100–125 nmol/l. Results Thirty-two postoperative patients with Crohn’s colitis had an average 25(OH)D concentration of 51.5 (range 25–74 nmol / L). 25 patients reached the target level and six patients reached 90–94 nmol / L. Because of the reoperation, one patient withdrew in 6 months. Patients with BMI <30 kg / m2 could reach the target dose (p = 0.006), and the total dose was negatively correlated with the initial serum 25(OH)D (Spearman r = 0.86, p = 0.002). One patient developed a high level (146 nmol/L) at 2 months and the other had new hypercalciuria. There are no serious adverse events attributable to treatment. Clinical disease activity continued to decline (p = 0.015), but faecal calprotectin (p = 0.264), inflammatory cycle markers (p = 0.513) and Rutgeerts score (p = 0.428) did not decrease. Conclusion Specific oral vitamin D regimens can successfully and safely reach or approach target levels, improve symptom-based activity scores, but do not alter objective indicators of intestinal or systemic inflammation. A modified version of this dose-escalation protocol is suitable for randomised placebo-controlled trials, and the further randomised controlled trial was needed.
What problem does this paper attempt to address?